This review aims to synthesize evidence on the association of circulating apelin with cancer, illustrate gaps in knowledge, and discuss potential methodological improvement in the more sensitive assessment of apelin levels and innovative approaches for future cancer research. This evidence concerns the gene APLN and cancer.